China, Trade Alerts

April 2, 2025
|
2 minute read

Removal of De Minimis Treatment for Products of China and Hong Kong

THOMPSON COBURN TRADE ALERT – IMPORTS
HEADLINERemoval of De Minimis Treatment for Products of China and Hong Kong
DATEApril 2, 2025
AGENCYDepartment of Homeland Security, Customs and Border Protection (CBP); Trump Administration
EFFECTIVE DATE12:01 am ET on May 2, 2025
BACKGROUNDTrump previously imposed additional 20% tariffs on products of China (10% effective February 4 and additional 10% effective March 4).  

An EO issued February 5 further amended the tariffs on China to eliminate duty-free de minimis treatment of products from China upon notification by the Secretary of Commerce that adequate systems were in place.
DETAILSPresident Trump amended his previous Executive Order to increase tariffs on products from China and Hong Kong to eliminate duty-free de minimis treatment under 19 U.S.C. 1321(a)(2)(C) once the Secretary of Commerce establishes adequate systems are in place to implement the Order. The April 2 Order states the Secretary of Commerce has notified the President that adequate systems are now in place for eliminating duty-free de minimis treatment on shipments valued less than $800 under Section 321.  

The current EO provides:
• 30% tariffs on shipments valued under $800.
• $25 tariff per postal item entered between May 2, 2025, and June 1, 2025.
• $50 tariff per postal item entered on or after 12:01 am ET June 1, 2025.
• Bond Requirement: Any carrier that transports international postal items containing goods from the PRC or Hong Kong to the United States, by any mode of transportation, must have an international carrier bond to ensure payment of the duty 
BASISInternational Emergency Economic Powers Act (50 U.S.C. 1701 et seq.) (IEEPA), the National Emergencies Act (50 U.S.C. 1601 et seq.), section 604 of the Trade Act of 1974 (19 U.S.C. 2483), and section 301 of title 3, United States Code.
HTS/
PRODUCTS
All
COUNTRYChina and Hong Kong
CITEFurther Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China as Applied to Low-Value Imports – The White House